BofA Finance LLC has filed a new SEC document revealing its plan to issue $204,000 in Contingent Income Issuer Callable Yield Notes. This initiative is significant as it represents a strategic move to diversify investment options for clients and enhance the company's financial offerings.
The notes are linked to the Nasdaq-100 Index and are fully and unconditionally guaranteed by Bank of America Corporation. The pricing for these notes occurred on October 27, 2026, and they are set to be issued on October 30, 2026. This development highlights BofA Finance's commitment to providing innovative financial products in a competitive market.
Background
BofA Finance LLC is a financial services company categorized under the SIC code 6021, which designates it as a national commercial bank. The company operates under the Central Index Key (CIK) number 0001682472. BofA Finance is incorporated in Delaware and is part of the broader Bank of America Corporation family, which is a significant player in the financial services industry.
What the Filing Says
The SEC filing, accession number 0001918704-26-033315, details the issuance of the Callable Yield Notes, stating: "The Notes will not be listed on any securities exchange." This indicates that the notes will be available through private placements rather than public trading, which may appeal to a specific investor demographic.
Impact
This issuance may affect various stakeholders, including investors looking for unique investment opportunities and financial advisors seeking new products for their clients. Additionally, the move could influence other national commercial banks as they respond to the competitive landscape created by such innovative offerings.
What's Next
The filing does not say what happens next. However, the issuance of these notes is expected to attract investor interest, particularly those focused on products linked to major market indices like the Nasdaq-100.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










